According to a new market
research report published by Global Market Estimates, the Global Clinical
Diagnostic Market is projected to grow at a CAGR of 6.5% from 2022 to 2027.
Major driving factors include changes in the lifestyle of individuals who lead unhealthy lives, which has resulted in a surge in diabetes, hypertension, and other cardiovascular problems, as well as continued advancement in the industry and the advent of contemporary apparatus.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global Clinical Diagnostic Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/clinical-diagnostic-market-3820
Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Siemens AG, Hologic Inc., Qiagen NV, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, and Quest Diagnostics Inc., among others, are some of the key players in the global clinical diagnostic market.
Type Outlook (Revenue, USD Billion, 2022-2027)
· Lipid Panel
· Liver Panel
· Renal Panel
· Complete Blood Count
· Electrolyte Testing
· Infectious Disease Testing
Application Outlook (Revenue, USD Billion, 2022-2027)
End-User Outlook (Revenue, USD Billion, 2022-2027)
· Hospital Laboratory
· Diagnostic Laboratory
· Point-of-care Testing
Regional Outlook (Revenue, USD Billion, 2022-2027)
Central & South America
Middle East & Africa
Contact: Yash Jain
Email address: email@example.com
Phone Number: +1 6026667238